GGrantIndex
Sort

261,768 grants matching gene therapy

The Hepato/Renal Fibrocystic Disease Core Center

$1,103,340
Bradley K. Yoder · University Of Alabama At Birmingham · P30 · FY2019 · DK

The Hepato/Renal Fibrocystic Disease Core Center

$1,103,340
Bradley K. Yoder · University Of Alabama At Birmingham · P30 · FY2017 · DK

Novel small-molecule therapies for CF

$1,103,274
University Of California San Francisco · P30 · FY2005 · DK

Broad Spectrum Neutralizing Human Abs to SARS and Related Coronaviruses

$1,103,251
Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2012 · AI

Host Defense Regulation and Viral Oncogenesis

$1,103,015
Glen N. Barber · University Of Miami School Of Medicine · P01 · FY2012 · CA

Chemical Proteomic Platforms for Radically Expanding Cancer Druggability

$1,102,950
Benjamin F Cravatt · Scripps Research Institute, The · R35 · FY2024 · CA

Role of inflammation in epigenetic alterations of metastatic cancer cells

$1,102,876
Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Development of a novel MYC inhibitor for cancer therapy

$1,102,729
Ben Vollrath · Vortex Therapeutics Inc · R44 · FY2025 · CA

DIRAS3 disrupts K-RAS clustering and signaling, enhancing autophagy and response to autophagy inhibition

$1,102,724
Robert C Bast · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Mechanisms of fenofibrate alone or combined with propranolol in burned patients

$1,102,701
David N Herndon · University Of Texas Med Br Galveston · R01 · FY2014 · GM

Defining the resistome in P. falciparum: evolution and mechanism

$1,102,586
Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2024 · AI

Drugs Targeting Dormant Tumors as Anti-Metastatic Agents

$1,102,521
Michael A Ihnat · Dormatarg, Inc. · R44 · FY2011 · CA

Pharmacogenomics of ART adherence and effectiveness in the ALIVE Cohort

$1,102,432
Brion S Maher · Johns Hopkins University · R01 · FY2023 · DA

MEMBRANE TRAFFIC IN NORMAL AND TRANSFORMED CELLS

$1,102,385
Yale University · P01 · FY2001 · CA

RESTORATION OF APOPTOSIS IN CANCER

$1,102,200
University Of Texas Md Anderson Can Ctr · P01 · FY2002 · CA

Plant Genome Engineering using DNA Replicons

$1,102,010
Daniel F Voytas · University Of Minnesota-Twin Cities · · FY2014 · BIO

Collaborative Expansion of Marmoset Colonies for Neuroscience Research

$1,101,889
Jon E Levine · University Of Wisconsin-Madison · U24 · FY2020 · MH

Unconventional protein secretion-mediated protein quality control in health and diseases

$1,101,807
Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

RCMI Center for Interdiscplinary Health Research CIHR

$1,101,680
George Perry · University Of Texas San Antonio · G12 · FY2016 · MD

Immunohistochemistry Core Laboratory

$1,101,677
Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria

$1,101,631
Ian Cyril Bathurst · Medicines For Malaria Venture · U01 · FY2009 · AI

Waisman Intellectual and Developmental Disabilities Research Center

$1,101,600
Albee Messing · University Of Wisconsin-Madison · U54 · FY2016 · HD

Waisman Intellectual and Developmental Disabilities Research Center

$1,101,600
Qiang Chang · University Of Wisconsin-Madison · U54 · FY2019 · HD

Waisman Intellectual and Developmental Disabilities Research Center

$1,101,600
Qiang Chang · University Of Wisconsin-Madison · U54 · FY2020 · HD

Waisman Intellectual and Developmental Disabilities Research Center

$1,101,600
Qiang Chang · University Of Wisconsin-Madison · U54 · FY2017 · HD